COVID-19 in the Asia Pacific: impact on climate change, allergic diseases and One Health

Author:

Pawankar Ruby1,Thong Bernard Y2,Recto Marysia3,Wang Jiu-Yao4,Abdul Latiff Amir Hamzah5,Leung Ting-Fan6,Li Philip H7,Lobo Rommel Crisenio M8,Lucas Michela9,Oh Jae-Won10,Kamchaisatian Wasu11,Nagao Mizuho12,Rengganis Iris13,Udwadia Zarir F14,Dhar Raja15,Munkhbayarlakh Sonomjamts16,Narantsetseg Logii17,L Pham Duy18,Zhang Yuan19,Zhang Luo20

Affiliation:

1. Department of Pediatrics, Nippon Medical School, Tokyo, Japan

2. Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore

3. Division of Allergy and Immunology, Department of Pediatrics, University of the Philippines-Philippine General Hospital, Manila, Philippines

4. Allergy, Immunology, and Microbiome (A.I.M.) Research Centre, China Medical University Children’s Hospital, Taichung, Taiwan

5. Allergy & Immunology Centre, Pantai Hospital Kuala Lumpur, Malaysia

6. Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong

7. Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong

8. Philippine Children’s Medical Center Hospital of Infant Jesus Medical Center, Fe Del Mundo Medical Center, Manila, Philippines

9. Department of Clinical Immunology, Sir Charles Gairdner Hospital, Perth Children’s Hospital, Pathwest; Medical School, University of Western Australia, Perth, WA, Australia

10. Department of Pediatrics, Hanyang University Guri Hospital, Guri, Korea

11. Pediatric Allergy and Immunology, Samitivej Children’s Hospital, Bangkok, Thailand

12. Institute for Clinical Research, National Hospital Organization Mie National Hospital, Tsu, Japan

13. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia

14. P.D. Hinduja National Hospital and Medical Research Centre and the Breach Candy Hospital, Mumbai, India

15. CMRI Hospital, Kolkata, West Bengal, India

16. Department of Pulmonology and Allergology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

17. Department of Biochemistry, School of Biomedicine, National University of Medical Sciences, Ulaanbaatar, Mongolia

18. Faculty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam

19. Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China

20. Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Abstract

Climate change and environmental factors such as air pollution and loss of biodiversity are known to have a major impact not only on allergic diseases but also on many noncommunicable diseases. Coronavirus disease 2019 (COVID-19) resulted in many environmental changes during the different phases of the pandemic. The use of face masks, enhanced hand hygiene with hand rubs and sanitizers, use of personal protective equipment (gowns and gloves), and safe-distancing measures, reduced the overall incidence of respiratory infections and other communicable diseases. Lockdowns and border closures resulted in a significant reduction in vehicular traffic and hence environmental air pollution. Paradoxically, the use of personal protective equipment and disposables contributed to an increase in environmental waste disposal and new problems such as occupational dermatoses, especially among healthcare workers. Environmental changes and climate change over time may impact the exposome, genome, and microbiome, with the potential for short- and long-term effects on the incidence and prevalence of the allergic disease. The constant use and access to mobile digital devices and technology disrupt work–life harmony and mental well-being. The complex interactions between the environment, genetics, immune, and neuroendocrine systems may have short- and long-term impact on the risk and development of allergic and immunologic diseases in the future.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3